Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Vagus nerve stimulation (VNS) had antidepressant effects in an initial open, acute phase pilot study of 59 participants in a treatment-resistant major depressive episode (MDE). We examined the effects of adjunctive VNS over 24 months in this cohort. METHOD: Adult outpatients (N = 59) with chronic or recurrent major depressive disorder or bipolar (I or II) disorder and experiencing a treatment-resistant, nonpsychotic MDE (DSM-IV criteria) received 2 years of VNS. Changes in psychotropic medications and VNS stimulus parameters were allowed only after the first 3 months. Response was defined as > or = 50% reduction from the baseline 28-item Hamilton Rating Scale for Depression (HAM-D-28) total score, and remission was defined as a HAM-D-28 score < or = 10. RESULTS: Based on last observation carried forward analyses, HAM-D-28 response rates were 31% (18/59) after 3 months, 44% (26/59) after 1 year, and 42% (25/59) after 2 years of adjunctive VNS. Remission rates were 15% (9/59) at 3 months, 27% (16/59) at 1 year, and 22% (13/59) at 2 years. By 2 years, 2 deaths (unrelated to VNS) had occurred, 4 participants had withdrawn from the study, and 81% (48/59) were still receiving VNS. Longer-term VNS was generally well tolerated. CONCLUSION: These results suggest that patients with chronic or recurrent, treatment-resistant depression may show long-term benefit when treated with VNS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several other studies also demonstrated an increasing long-term benefit of VNS in recurrent treatment-resistant depression (84, 85, 115).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [115]
Citations
Cites
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“Gender, female, N (%) 38 (65) White, N (%) 58 (98) Hispanic, N (%) 1 (2) MDD, recurrent, N (%) 27 (46) MDD, single episode, N (%) 16 (27) Bipolar I disorder, N (%) 6 ( 10 ) Bipolar II disorder, N (%) 10 (17) Baseline HAM-D-28 score”
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
(1976) · Medical Entomology and Zoology · Cited by 8,899
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Sackeim, H. A., Prudic, J., Devanand, D. P., Nobler, M. S., Lisanby, S. H., Peyser, S., Fitzsimons, L., Moody, B. J., & Clark, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.425 · Cited by 804
Self-citation(2001) · PubMed · Cited by 780
Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy
Morris, G. L., Mueller, W. M., & The Vagus Nerve Stimulation Study Group E–E (1999) · Neurology · doi:10.1212/wnl.53.8.1731 · Cited by 724
Rush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688
Self-citationSackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Cited by
Brain foods: The effects of nutrients on brain function.
Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372
“; however, in a longer-term study (lasting 12 months), VNS produced beneficial effects that were sustained after 2 year”
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,520
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“Several other studies also demonstrated an increasing long-term benefit of VNS in recurrent treatmentresistant depression (84, 85, 115).”
BackgroundHeart rate variability biofeedback: how and why does it work?
Lehrer, P. M., & Gevirtz, R. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00756 · Cited by 883
“One possible clue came from the recent research using vagal nerve stimulation for severe depression (and seizure disorders; Sackeim et al., 2001a,b; Nahas et al., 2005; Daban et al., 2008; George et al., 2008; Cristancho et al., 2011).”
BackgroundCognitive therapy versus medication for depression: treatment outcomes and neural mechanisms
DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2345 · Cited by 690
Holtzheimer, P. E., Husain, M. M., Lisanby, S. H., Taylor, S. F., Whitworth, L. A., McClintock, S., Slavin, K. V., Berman, J., McKhann, G. M., Patil, P. G., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30371-1 · Cited by 577
Self-citationA review of vagus nerve stimulation as a therapeutic intervention
Johnson, R. L., & Wilson, C. G. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s163248 · Cited by 562
“A study conducted by Nahas et al showed patients with chronic or recurrent major depressive disorder receiving VNS may have beneficial long-term outcomes.(41) In their study, 42% of their patients experienced a positive effect and 22% saw remission after 2 years.”
Kennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Nemeroff, C. B., Mayberg, H. S., Krahl, S. E., McNamara, J., Frazer, A., Henry, T. R., George, M. S., Charney, D. S., & Brannan, S. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301082 · Cited by 496
“The 59 patients who completed the short-term pilot study (Rush et al, 2000; Sackeim et al, 2001a) and met response criteria at 3 months (early responders) or 1 year (late responders) were followed for a total of 2 years (Nahas et al, 2005).”
BackgroundSelf-citationPrognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Stuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 430
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777193 · Cited by 454
Karavidas, M. K., Lehrer, P. M., Vaschillo, E., Vaschillo, B., Marin, H., Buyske, S., Malinovsky, I., Radvanski, D., & Hassett, A. (2007) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-006-9029-z · Cited by 440
“and worldwide is high and likely to grow (Eaton et al., 1989; Murray & Lopez, 1996 ).”
BackgroundEffect of vagus nerve stimulation on serotonergic and noradrenergic transmission
Dorr, A. E., & Debonnel, G. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104166 · Cited by 420
Brain stimulation for epilepsy
Theodore, W. H., & Fisher, R. S. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00664-1 · Cited by 410
George, M. S., & Aston-Jones, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.87 · Cited by 401
Self-citationHowland, R. H. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0010-5 · Cited by 405
“During follow-up of 59 patients, 44% were responders (27% remitters) at one year [36] and 42% were responders (22% remitters) at two years [37].”
Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression
Guo, B., Zhang, M., Hao, W., Wang, Y., Zhang, T., & Liu, C. (2023) · Translational Psychiatry · doi:10.1038/s41398-022-02297-y · Cited by 374
Mechanisms of long COVID and the path toward therapeutics
Peluso, M. J., & Deeks, S. G. (2024) · Cell · doi:10.1016/j.cell.2024.07.054 · Cited by 341
Ben‐Menachem, E., Revesz, D., Simon, B. J., & Silberstein, S. (2015) · European Journal of Neurology · doi:10.1111/ene.12629 · Cited by 344
Koenig, J., Kemp, A. H., Beauchaine, T. P., Thayer, J. F., & Kaess, M. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.04.013 · Cited by 285
Treatment-resistant depression and suicidality
Bergfeld, I. O., Mantione, M., Figee, M., Schuurman, P. R., Lok, A., & Denys, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.016 · Cited by 256
Dietrich, S., Smith, J., Scherzinger, C., Hofmann-Preiß, K., Freitag, T., Eisenkolb, A., & Ringler, R. (2008) · Biomedizinische Technik/Biomedical Engineering · doi:10.1515/bmt.2008.022 · Cited by 252
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders
George, M. S., Ward, H. E., Ninan, P. T., Pollack, M., Nahas, Z., Anderson, B., Kose, S., Howland, R. H., Goodman, W. K., & Ballenger, J. C. (2008) · Brain Stimulation · doi:10.1016/j.brs.2008.02.001 · Cited by 251
Self-citationConsensus statement: The evaluation and treatment of people with epilepsy and affective disorders
Barry, J. J., Ettinger, A. B., Friel, P., Gilliam, F. G., Harden, C. L., Hermann, B., Kanner, A. M., Caplan, R., Plioplys, S., Salpekar, J., et al. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.04.005 · Cited by 249
Manta, S., Dong, J., Debonnel, G., & Blier, P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0936 · Cited by 217
How can drug discovery for psychiatric disorders be improved?
Agid, Y., Buzsáki, G., Diamond, D. M., Frackowiak, R., Giedd, J., Girault, J.-A., Grace, A., Lambert, J. J., Manji, H., Mayberg, H., et al. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2217 · Cited by 240
Kennedy, S. H., Milev, R., Giacobbe, P., Ramasubbu, R., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.039 · Cited by 222
A Comprehensive Review of Vagus Nerve Stimulation for Depression
Austelle, C. W., O'Leary, G. H., Thompson, S., Gruber, E., Kahn, A., Manett, A. J., Short, B., & Badran, B. W. (2022) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.13528 · Cited by 201
The serotonin axis: Shared mechanisms in seizures, depression, and SUDEP
Richerson, G. B., & Buchanan, G. F. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02908.x · Cited by 216
“It was found in one trial that VNS reduces depressive symptoms by 42% at 24 months (Nahas et al., 2005), an amount that is equivalent to the effect of VNS on A B Epilepsia, 52(Suppl.”
ResultTherapeutic Options for Treatment-Resistant Depression
Shelton, R. C., Osuntokun, O., Heinloth, A. N., & Corya, S. A. (2010) · CNS Drugs · doi:10.2165/11530280-000000000-00000 · Cited by 205
Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms
Wang, Y., Zhan, G., Cai, Z., Jiao, B., Zhao, Y., Li, S., & Luo, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.018 · Cited by 206
Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus
Biggio, F., Gorini, G., Utzeri, C., Olla, P., Marrosu, F., Mocchetti, I., & Follesa, P. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000200 · Cited by 203
Vagal nerve stimulation for treatment-resistant depression
Carreno, F. R., & Frazer, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0537-8 · Cited by 208
Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice
Siopi, E., Galerne, M., Rivagorda, M., Saha, S., Moigneu, C., Moriceau, S., Bigot, M., Oury, F., & Lledo, P.-M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02071-6 · Cited by 180
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
“Although response rates with VNS have been modest in the acute phase of treatment (Daban et al. 2008), open label extension phases suggest an increased effect over time (Nahas et al. 2005).”
BackgroundWhite, B. A., Horwath, C. C., & Conner, T. S. (2013) · British Journal of Health Psychology · doi:10.1111/bjhp.12021 · Cited by 170
Crowell, A. L., Riva-Posse, P., Holtzheimer, P. E., Garlow, S. J., Kelley, M. E., Gross, R. E., Denison, L., Quinn, S., & Mayberg, H. S. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18121427 · Cited by 182
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178
Neurohemodynamic correlates of ′OM′ chanting: A pilot functional magnetic resonance imaging study
Gangadhar, B., Kalyani, B., Venkatasubramanian, G., Arasappa, R., Rao, N., Kalmady, S., Behere, R., Rao, H., & Vasudev, M. (2011) · International Journal of Yoga · doi:10.4103/0973-6131.78171 · Cited by 175
Aaronson, S. T., Carpenter, L. L., Conway, C. R., Reimherr, F. W., Lisanby, S. H., Schwartz, T. L., Moreno, F. A., Dunner, D. L., Lesem, M. D., Thompson, P. M., et al. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.09.013 · Cited by 163
Self-citationDaban, C., Martinez-Aran, A., Cruz, N., & Vieta, E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.02.012 · Cited by 163
Thompson, S. L., O’Leary, G. H., Austelle, C. W., Gruber, E., Kahn, A. T., Manett, A. J., Short, B., & Badran, B. W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.709436 · Cited by 175
Serial Vagus Nerve Stimulation Functional MRI in Treatment-Resistant Depression
Nahas, Z. H., Tenebäck, C. C., Chae, J., Mu, Q., Molnar, C., Kozel, F. A., Walker, J., Anderson, B. S., Koola, J., Köse, S., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301288 · Cited by 184
Self-citationUse of Antiepileptic Drugs for Nonepileptic Conditions: Psychiatric Disorders and Chronic Pain
Ettinger, A. B., & Argoff, C. E. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.10.003 · Cited by 169
Transcutaneous vagus nerve stimulation - A brief introduction and overview
Hilz, M. J. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.103038 · Cited by 157
Olin, B., Berry, Broglio, Bunker, Jayewardene, & Rush (2013) · Medical Devices: Evidence and Research · doi:10.2147/mder.s41017 · Cited by 152
Self-citationSomatic Treatments for Mood Disorders
Rosa, M. A., & Lisanby, S. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.225 · Cited by 156
Self-citationBottomley, J. M., LeReun, C., Diamantopoulos, A., Mitchell, S., & Gaynes, B. N. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152156 · Cited by 138
Vagus Nerve Stimulation for Epilepsy and Depression
Milby, A. H., Halpern, C. H., & Baltuch, G. H. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.071 · Cited by 141
“nonresponders to responders during the same time period.(85) Responders to VNS (31%) in one study exhibited remarkable improvement in most aspects of QOL; how-”
BackgroundInfluentialVagus nerve stimulation in psychiatry: a systematic review of the available evidence
Cimpianu, C.-L., Strube, W., Falkai, P., Palm, U., & Hasan, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1642-2 · Cited by 138
Vagus nerve stimulation (VNS): recent advances and future directions
Austelle, C. W., Cox, S. S., Wills, K. E., & Badran, B. W. (2024) · Clinical Autonomic Research · doi:10.1007/s10286-024-01065-w · Cited by 147
Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation
Revesz, D., Tjernstrom, M., Ben-Menachem, E., & Thorlin, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.012 · Cited by 126
Durability of antidepressant response to vagus nerve stimulation (VNS)
Sackeim, H. A., Brannan, S. K., Rush, A. J., George, M. S., Marangell, L. B., & Allen, J. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007425 · Cited by 118
Self-citationOpen water swimming as a treatment for major depressive disorder
van Tulleken, C., Tipton, M., Massey, H. C., & Harper, C. M. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225007 · Cited by 130
Graded recruitment of pupil-linked neuromodulation by parametric stimulation of the vagus nerve
Mridha, Z., de Gee, J. W., Shi, Y., Alkashgari, R., Williams, J. C., Suminski, A. J., Ward, M. P., Zhang, W., & McGinley, M. J. (2021) · Nature Communications · doi:10.1038/s41467-021-21730-2 · Cited by 125
Advances in the treatment of depression
Holtzheimer, P. E., & Nemeroff, C. B. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.007 · Cited by 141
WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry
Schlaepfer, T. E., George, M. S., & Helen Mayberg on behalf of the WFSBP Task Force on Brain Stimulation (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903170835 · Cited by 114
Self-citationFurmaga, H., Shah, A., & Frazer, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.020 · Cited by 116
“Two-factor ANOVA revealed a significant interaction beween drug treatment lesion for immobility [F (4,72) 13.”
Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression
Nahas, Z., Anderson, B. S., Borckardt, J., Arana, A. B., George, M. S., Reeves, S. T., & Takacs, I. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.021 · Cited by 111
Self-citationRecognizing the role of the vagus nerve in depression from microbiota-gut brain axis
Tan, C., Yan, Q., Ma, Y., Fang, J., & Yang, Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1015175 · Cited by 130
Bernal‐Mizrachi, C., Xiaozhong, L., Li, Y., Knutsen, R. H., Howard, M. J., Arends, J. J. A., DeSantis, P., Coleman, T., & Semenkovich, C. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.12.010 · Cited by 115
Treatment Resistant Depression— Advances in Somatic Therapies
Kennedy, S. H., & Giacobbe, P. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701675222 · Cited by 104
Neurostimulation therapies in depression: a review of new modalities
Marangell, L. B., Martinez, M., Jurdi, R. A., & Zboyan, H. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01033.x · Cited by 103
Self-citationFurmaga, H., Carreno, F. R., & Frazer, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034844 · Cited by 99
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B., Brand, U., Fleischhacker, W., Goodwin, G., Grunze, H., Knapp, M., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98
Therapeutic options in treatment-resistant depression
Vieta, E., & Colom, F. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.583675 · Cited by 102
Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders
Broncel, A., Bocian, R., Kłos‐Wojtczak, P., Kulbat-Warycha, K., & Konopacki, J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.011 · Cited by 108
Central afferents to the nucleus of the solitary tract in rats and mice
Gasparini, S., Howland, J. M., Thatcher, A. J., & Geerling, J. C. (2020) · Journal of Comparative Neurology · doi:10.1002/cne.24927 · Cited by 90
Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data
Cecchini, A. P., Mea, E., Tullo, V., Curone, M., Franzini, A., Broggi, G., Savino, M., Bussone, G., & Leone, M. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0073-3 · Cited by 100
Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS
Cusin, C., & Dougherty, D. D. (2012) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-2-14 · Cited by 98
“sponse and remission rates [43,44].”
Kanner, A. M., Schachter, S. C., Barry, J. J., Hersdorffer, D. C., Mula, M., Trimble, M., Hermann, B. P., Ettinger, A. E., Dunn, D., Caplan, R., et al. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.01.008 · Cited by 108
Deep Brain Stimulation for Treatment-Resistant Depression
Holtzheimer, P. E., & Mayberg, H. S. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10010141 · Cited by 93
Vagus Nerve Stimulation (VNS) and Treatment of Depression: To the Brainstem and Beyond.
O’Reardon, J. P., Cristancho, P., & Peshek, A. D. (2006) · PubMed · Cited by 182
Intraoperative and perioperative complications with a vagus nerve stimulation device
Fahy, B. G. (2010) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2009.10.002 · Cited by 95
Guiraud, D., Andreu, D., Bonnet, S., Carrault, G., Couderc, P., Hagège, A., Henry, C., Hernandez, A., Karam, N., Le Rolle, V., et al. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/4/041002 · Cited by 87
Taeye, L. D., Vonck, K. E. J., van Bochove, M. E., Boon, P., Roost, D. V., Mollet, L., Meurs, A., Herdt, V. D., Carrette, E., Dauwe, I., et al. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0272-3 · Cited by 107
Treatment strategies to improve and sustain remission in major depressive disorder
Madhukar H., T., & Ella J., D. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/mhtrivedi · Cited by 75
Hong, G., Zillekens, A., Schneiker, B., Pantelis, D., de Jonge, W. J., Schaefer, N., Kalff, J. C., & Wehner, S. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13501 · Cited by 94
Assessment and treatment of suicide risk in bipolar disorders
Pompili, M., Rihmer, Z., Innamorati, M., Lester, D., Girardi, P., & Tatarelli, R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.1.109 · Cited by 80
The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
Grimonprez, A., Raedt, R., Baeken, C., Boon, P., & Vonck, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.019 · Cited by 81
Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: A review
Moreines, J. L., McClintock, S. M., & Holtzheimer, P. E. (2011) · Brain Stimulation · doi:10.1016/j.brs.2010.01.005 · Cited by 78
Heart and soul: heart rate variability and major depression
Kidwell, M., & Ellenbroek, B. A. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000387 · Cited by 86
Pardo, J. V., Sheikh, S. A., Schwindt, G. C., Lee, J. T., Kuskowski, M. A., Surerus, C., Lewis, S. M., Abuzzahab, F. S., Adson, D. E., & Rittberg, B. R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.267 · Cited by 79
Brain stimulation for epilepsy
Theodore, W. H., & Fisher, R. S. (2007) · Springer eBooks · doi:10.1007/978-3-211-33081-4_29 · Cited by 84
Direct measurement of vagal tone in rats does not show correlation to HRV
Marmerstein, J. T., McCallum, G. A., & Durand, D. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79808-8 · Cited by 77
Conway, C. R., Sheline, Y. I., Chibnall, J. T., Bucholz, R. D., Price, J. L., Gangwani, S., & Mintun, M. A. (2012) · Brain Stimulation · doi:10.1016/j.brs.2011.03.001 · Cited by 77
Schrader, L. M., Cook, I. A., Miller, P. R., Maremont, E. R., & DeGiorgio, C. M. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.06.026 · Cited by 80
Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy
Klinkenberg, S., Majoie, M., van der Heijden, M. M. A. A., Rijkers, K., Leenen, L. A. M., & Aldenkamp, A. P. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.11.016 · Cited by 76
Brain stimulation for the treatment of psychiatric disorders
George, M. S., Nahas, Z., Borckardt, J. J., Anderson, B., Foust, M. J., Burns, C., Kose, S., & Short, E. B. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280ad4698 · Cited by 75
Self-citationConway, C. R., Chibnall, J. T., Gebara, M. A., Price, J. L., Snyder, A. Z., Mintun, M. A., Craig, A. D. (., Cornell, M. E., Perantie, D. C., Giuffra, L. A., et al. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.11.006 · Cited by 75
“Further, unlike ECT and other preferred TRMD treatments, patients who respond to VNS tend to maintain their response [5].”
BackgroundThe antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus
Grimonprez, A., Raedt, R., Portelli, J., Dauwe, I., Larsen, L. E., Bouckaert, C., Delbeke, J., Carrette, E., Meurs, A., Herdt, V. D., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.05.002 · Cited by 86
Emerging targets for antidepressant therapies
Rakofsky, J. J., Holtzheimer, P. E., & Nemeroff, C. B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.617 · Cited by 72
Farrand, A. Q., Verner, R., McGuire, R. M., Helke, K. L., Hinson, V. K., & Boger, H. A. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.06.078 · Cited by 74
Engineer, C. T., Hays, S. A., & Kilgard, M. P. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9203-z · Cited by 72
Kopell, B. H., Halverson, J., Butson, C. R., Dickinson, M., Bobholz, J., Harsch, H., Rainey, C., Kondziolka, D., Howland, R., Eskandar, E., et al. (2011) · Neurosurgery · doi:10.1227/neu.0b013e318229cfcd · Cited by 68
Perez, S. M., Carreno, F. R., Frazer, A., & Lodge, D. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0588-14.2014 · Cited by 65
“…authors 0270-6474/14/349261-07$15.00/0 reducing seizure frequency and improving depression rating scales over time with few associated side effects (Morris and Mueller, 1999; Elger et al., 2000; Harden et al., 2000; George et al., 2005; Nahas et al., 2005; Rush et al., 2005b; Kuba et al., 2009).”
BackgroundInfluentialOlin, B., Jayewardene, A. K., Bunker, M., & Moreno, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048002 · Cited by 63
Prognosis and Improved Outcomes in Major Depression: A Review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2020) · Focus · doi:10.1176/appi.focus.18205 · Cited by 62
Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders
George, M. S., Nahas, Z., Borckardt, J. J., Anderson, B., Burns, C., Kose, S., & Short, E. B. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.1.63 · Cited by 61
Self-citation
Metadata
- Authors
- Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S.
- Affiliations
- Medical University of South Carolina (US)
- Baylor College of Medicine (US)
- The University of Texas Southwestern Medical Center (US)
- Columbia University (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2005-09-15
- Volume
- 66
- Issue
- 09
- Pages
- 1097-1104
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1990716006
- Cited by
- 390
- References
- 13
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 16 · 2023: 10 · 2022: 12 · 2021: 21 · 2020: 14 · 2019: 31 · 2018: 20 · 2017: 8 · 2016: 13 · 2015: 15 · 2014: 20 · 2013: 14 · 2012: 24
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- vagus nerve stimulation, treatment-resistant depression, major depressive episode, bipolar disorder, adjunctive therapy, long-term outcomes, remission, antidepressant effects, tolerability
- MeSH terms
- Ambulatory Care, Cholestyramine Resin, Chronic Disease, Combined Modality Therapy, Major Depressive Disorder, Depressive Disorder, Major, Electroconvulsive Therapy, Electric Stimulation Therapy, Female, Follow-Up Studies, Health Status, Humans, Male, Middle Aged, Pilot Projects, Psychiatric Status Rating Scales, Psychotropic Drugs, Recurrence, Vagus Nerve, Cohort Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.